BAF312
Showing 1 - 13 of 13
Secondary Progressive Multiple Sclerosis Trial in Germany (BAF312, Baseline disease modifying therapies (DMTs))
Active, not recruiting
- Secondary Progressive Multiple Sclerosis
- BAF312
- Baseline disease modifying therapies (DMTs)
-
Mittweida, Sachsen, Germany
- +9 more
Aug 9, 2022
Renal Impairment Trial in Orlando, Bucuresti (BAF312)
Completed
- Renal Impairment
- BAF312
-
Orlando, Florida
- +1 more
Dec 6, 2020
Phase III Trial With BAF312 in Secondary Progressive Multiple
Completed
- Secondary Progressive Multiple Sclerosis
- Blood Draw
- CSF collection by lumbar puncture (Optional)
-
Berkeley, California
- +12 more
Nov 5, 2020
Polymyositis, Dermatomyositis Trial in Worldwide (BAF312, Placebo)
Terminated
- Polymyositis
- Dermatomyositis
- BAF312
- Placebo
-
Boston, Massachusetts
- +5 more
Apr 3, 2019
Relapsing-remitting Multiple Sclerosis Trial in Worldwide (BAF312, Placebo)
Completed
- Relapsing-remitting Multiple Sclerosis
- BAF312
- Placebo
-
Cullman, Alabama
- +71 more
Dec 26, 2019
Relapsing Remitting Multiple Sclerosis Trial in Worldwide (BAF312)
Completed
- Relapsing Remitting Multiple Sclerosis
- BAF312
-
Miami, Florida
- +45 more
Feb 27, 2018
ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
Not yet recruiting
- Relapsing Multiple Sclerosis
- Blood withdrawal
-
Pozzilli, Isernia, ItalyIRCCS Neuromed
Oct 7, 2019
Multiple Sclerosis, Spasticity Trial in Pozzilli (lumbar puncture and blood withdrawal, Intermittent theta burst stimulation
Not yet recruiting
- Multiple Sclerosis
- Spasticity
- lumbar puncture and blood withdrawal
- Intermittent theta burst stimulation (iTBS) therapeutic protocol for spasticity
-
Pozzilli, Isernia, ItalyIRCCS Neuromed
Jul 2, 2019
Healthy Trial in East Hanover (BAF 312)
Completed
- Healthy
- BAF 312
-
East Hanover, New JerseyNovartis
Nov 28, 2007